We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBAN icon
626
CALL
Huntington Bancshares
HBAN
$35.9B
– –
-30,200
Closed -$3.02K
HBAN icon
627
Huntington Bancshares
HBAN
$35.9B
– –
-6,653
Closed -$93.8K
HIPO icon
628
Hippo Holdings
HIPO
$881M
– –
-10,300
Closed -$140K
HIX
629
Western Asset High Income Fund II
HIX
$355M
– –
-50,140
Closed -$243K
PPLI
630
PUT
People Inc
PPLI
$2.97B
– –
-81,673
Closed -$365K
IDXX icon
631
Idexx Laboratories
IDXX
$46.2B
– –
-497
Closed -$203K
IQV icon
632
IQVIA
IQV
$40.1B
– –
-1,020
Closed -$209K
ISRG icon
633
Intuitive Surgical
ISRG
$142B
– –
-894
Closed -$237K
KRE icon
634
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.61B
– –
-55,000
Closed -$439K
LANV.WS
635
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
– –
-159,118
Closed -$47.7K
LCID icon
636
CALL
Lucid Motors
LCID
$2.64B
– –
-500
Closed -$25
LNZA icon
637
LanzaTech
LNZA
$69M
– –
-727
Closed -$726K
LNZAW icon
638
LanzaTech Global Warrant
LNZAW
– –
-139,622
Closed -$33.5K
LUNG icon
639
Pulmonx
LUNG
$97.1M
– –
-5,126
Closed -$43.2K
LUNG icon
640
PUT
Pulmonx
LUNG
$97.1M
– –
-6,700
Closed -$2.51K
MASI
641
CALL
DELISTED
Masimo
MASI
– –
-40,000
Closed -$50K
MBI icon
642
CALL
MBIA
MBI
$253M
– –
-15,400
Closed -$18.5K
MBI icon
643
MBIA
MBI
$253M
– –
-177,296
Closed -$2.28M
MBI icon
644
PUT
MBIA
MBI
$253M
– –
-222,700
Closed -$52.7K
MRK icon
645
Merck
MRK
$322B
– –
-24,969
Closed -$2.77M
MRK icon
646
PUT
Merck
MRK
$322B
– –
-36,700
Closed -$65.7K
MRNA icon
647
CALL
Moderna
MRNA
$24.2B
– –
-6,400
Closed -$138
MRNA icon
648
Moderna
MRNA
$24.2B
– –
-16,324
Closed -$2.93M
MRNA icon
649
PUT
Moderna
MRNA
$24.2B
– –
-16,300
Closed -$4.42M
MSAI icon
650
MultiSensor AI
MSAI
$10.8M
– –
-1,638
Closed -$668K
24 25
26
27 28

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.